# Esketamine Combined With Pregabalin on CPSP in Spinal Patients.

> **NCT06117917** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Esketamine
- Pregabaline
- Chronic Post Operative Pain

## Interventions

- **DRUG:** S-ketamine and pregabalin
- **DRUG:** Normal saline and placebo capsule

## Key facts

- **NCT ID:** NCT06117917
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-10
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06117917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06117917, "Esketamine Combined With Pregabalin on CPSP in Spinal Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06117917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*